Similar articles

• Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.

  Olsson AG, Orö L, Rössner S. Olsson AG, et al. Atherosclerosis. 1974 Jan-Feb;19(1):61-73. doi: 10.1016/0021-9150(74)90044-6. Atherosclerosis. 1974. PMID: 4359183 No abstract available.
• Subacute administration of pentaerythritoltetranicotinate (Perycit) to man.

  Harthon L, Svedmyr N. Harthon L, et al. Atherosclerosis. 1974 Jul-Aug;20(1):65-8. doi: 10.1016/0021-9150(74)90079-3. Atherosclerosis. 1974. PMID: 4617581 Clinical Trial. No abstract available.
• Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.

  Olsson AG, Orö L, Rössner S. Olsson AG, et al. Atherosclerosis. 1975 Jul-Aug;22(1):91-101. doi: 10.1016/0021-9150(75)90070-2. Atherosclerosis. 1975. PMID: 1098680 Clinical Trial.
• Hypolipaemic drugs and coronary heart disease.

  Howard AN. Howard AN. J Clin Pathol Suppl (R Coll Pathol). 1975;9:106-14. J Clin Pathol Suppl (R Coll Pathol). 1975. PMID: 783209 Free PMC article. Review. No abstract available.
• Lipid lowering drugs.

  O'Connor P, Feely J, Shepherd J. O'Connor P, et al. BMJ. 1990 Mar 10;300(6725):667-72. doi: 10.1136/bmj.300.6725.667. BMJ. 1990. PMID: 2182155 Free PMC article. Review. No abstract available.